| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.09 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |